Drugs with this side effect
- 4-AP
- 5-ASA: postmarketing
- BCNU: 5%
- CAS 76095-16-4
- CGP 19835A: common
- Cancidas: 0% - 7.9%
- D-cycloserine
- EDTA
- Enfuvirtide: 1.9% - 2.2%
- FK463
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 13% - 14%
- Glat copolymer
- Histrelin
- Insulin
- K779
- Kaluril
- L-Dmp: postmarketing
- LY146032: postmarketing, uncommon
- Leuprorelin
- LiOH
- Lisinopril
- MK-462
- Mersyndol
- NovoLog
- Octreotide
- Optison: postmarketing
- PGE2
- Photofrin II: uncommon
- Stalevo 50
- Supremon
- TlCl
- VACV: very rare, postmarketing, 4%
- Vallergan
- Zyprexa Relprevv
- acamprosate
- acetaminophen
- acyclovir: very rare, postmarketing
- adenosine
- agomelatine
- allopurinol
- almotriptan: infrequent
- alosetron: rare
- alpha-methyl-p-tyrosine
- alprazolam: frequent, 0.4% - 28.2%
- amantadine: postmarketing, rare
- amikacin
- amiloride: postmarketing
- aminophylline: 14% - 38%
- amiodarone
- amisulpride: very common, 3% - 4%
- amitriptyline: postmarketing
- amlodipine
- amlodipine besylate
- amoxapine
- amphetamine
- amphotericin B
- amprenavir: common
- anthracycline
- aprepitant
- argenine vasopressin
- aripiprazole: 2% - 10%
- arsenic
- arsenic trioxide
- asenapine: 1.23% - 2.22%
- atomoxetine: uncommon, 2%
- baclofen: common, 0% - 1.33%
- benzathine penicillin
- benzonatate
- benzphetamine
- bepridil: 0% - 9.3%
- betaxolol
- bisoprolol
- bortezomib
- bosentan
- brinzolamide
- bromazepam: postmarketing
- budesonide
- bupivacaine
- buprenorphine: 2%
- bupropion: 1% - 21.1%
- buspirone: 1%
- butorphanol: infrequent
- cabozantinib
- capecitabine
- carbamazepine: postmarketing, uncommon, 3%
- carbidopa
- carbinoxamine
- carisoprodol: postmarketing
- cefaclor
- ceftazidime
- celiprolol
- cerivastatin
- cetirizine: postmarketing
- cevimeline
- chlorambucil
- chloroprocaine
- chlorpheniramine
- chlorpromazine
- cidofovir
- cilazapril
- ciprofloxacin: postmarketing, rare
- cisplatin
- citalopram: postmarketing, infrequent, frequent, 8% - 8.8%
- clarithromycin: postmarketing, uncommon
- clemastine
- clobazam: 1.3%
- clofarabine: common
- clomipramine: very common, 33% - 54%
- clonazepam
- clonidine: 1% - 3%
- clorazepate
- clozapine: 6%
- cocaine
- codeine
- colestimide: uncommon
- copolymer 1
- cyclizine
- cyclobenzaprine: 6%
- cyclopentolate
- cyclophosphamide: postmarketing
- cyproheptadine
- cysteamine
- cytarabine: 8.56% - 18%
- danazol
- dasatinib: uncommon
- delamanid
- delavirdine
- deprenyl: postmarketing, infrequent, 3%
- desipramine
- desvenlafaxine: 2% - 9%
- dexrazoxane
- diatrizoate
- dichlorphenamide
- diclofenac: very rare
- diethylpropion
- dihydroergotamine: infrequent
- diltiazem
- diphenhydramine
- dipyridamole: 0.1%
- dolasetron
- donepezil: frequent
- dothiepin
- doxazosin: 1.1%
- doxepin: rare
- duloxetine: 0% - 5%
- efavirenz: postmarketing, uncommon
- eletriptan: infrequent
- entacapone: 5%
- ephedrine
- eprosartan
- ertapenem: postmarketing
- eslicarbazepine
- eslicarbazepine acetate
- esomeprazole magnesium
- estazolam: rare
- estradiol: postmarketing
- etodolac: postmarketing
- etoricoxib
- etravirine
- everolimus: 12%
- febuxostat
- felbamate: 6.1%
- felodipine
- fenoprofen
- fentanyl: very rare, postmarketing, 0% - 3%
- flecainide: 2% - 4.7%
- fluconazole: postmarketing
- flumazenil
- flunitrazepam: common
- fluorescein: postmarketing
- fluoxetine: very common, 3% - 13.7%
- fluphenazine decanoate
- flurbiprofen
- fluticasone furoate
- fluticasone/salmeterol: uncommon
- fluvastatin: postmarketing
- fluvoxamine: common, frequent, 0% - 10.8%
- formoterol: common, 1.9% - 4%
- foscarnet
- fosinopril
- fosinoprilat
- fosphenytoin: 3.3% - 13.1%
- frovatriptan: infrequent
- gabapentin: 3.2% - 14.8%
- gadobenate dimeglumine
- gadodiamide
- gadofosveset
- gadolinium: postmarketing
- gadopentetate: postmarketing
- gadoteridol: postmarketing
- gadoversetamide
- galantamine: 2% - 3%
- ganciclovir: 12% - 28%
- gatifloxacin: postmarketing
- gemifloxacin
- glibenclamide
- gliclazide
- glimepiride
- glipizide: 3.6%
- granisetron
- guanfacine: postmarketing
- guanidinium
- haloperidol
- hydralazine: very rare
- hydrochlorothiazide
- hydrocodone: 0.196% - 2.65%
- hydromorphone
- hydroxybutyrate: 0% - 5%
- hydroxyzine
- ibuprofen
- iloperidone: 2.5% - 3.1%
- imatinib: uncommon
- imipramine: very common
- indacaterol
- indinavir
- insulin detemir
- iodipamide
- iohexol
- iopamidol
- iopromide: postmarketing
- ioversol
- ipratropium bromide: 0.9% - 31.9%
- irbesartan: rare
- irbesartan-hydrochlorothiazide
- isocarboxazid
- isomannide
- isoproterenol
- isosorbide-5-mononitrate
- itraconazole
- ivermectin: 0.9%
- ketorolac
- ketorolac tromethamine
- labetalol
- lacosamide: 0% - 12%
- lamivudine
- lamotrigine: 0.9% - 10%
- lansoprazole
- lenalidomide: postmarketing, 21.2%
- leuprorelin acetate
- levetiracetam: 1.5%
- levodopa/carbidopa
- lidocaine
- lisdexamfetamine dimesylate: postmarketing, 2%
- lithium
- lithium carbonate
- lomefloxacin
- lorazepam: infrequent
- lorcaserin
- losartan
- lovastatin: postmarketing
- loxapine: uncommon
- lubiprostone
- lurasidone
- maprotiline: 3%
- maraviroc
- mecamylamine
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine: postmarketing
- meloxicam
- memantine: infrequent
- meperidine
- mephenytoin
- mepivacaine
- metaproterenol: 16.9% - 84%
- metformin
- methadone
- methamphetamine
- methylene blue
- methylphenidate: common, 2.7% - 3.4%
- metoclopramide: postmarketing
- metronidazole
- mexiletine: 1.4% - 13.2%
- mianserin: common
- midazolam
- miglustat: 0% - 33%
- milnacipran: 2%
- milrinone
- mirtazapine: postmarketing, 1.55% - 2%
- mitotane
- moclobemide
- modafinil: postmarketing, 1%
- molindone
- montelukast: postmarketing
- morphine: 2%
- moxifloxacin
- mycophenolate mofetil: 2.1% - 35.5%
- mycophenolic acid: 11.7% - 35.5%
- nabilone
- nabumetone: 0.1%
- nalbuphine
- nalmefene
- naltrexone: postmarketing
- naproxen
- naratriptan: infrequent
- nateglinide
- nedocromil sodium
- nefazodone
- nelarabine: 0% - 5%
- nicardipine
- nicotine
- nifedipine: 8%
- nilotinib: uncommon
- nisoldipine
- nitazoxanide
- nitrazepam
- norfloxacin: postmarketing
- nortriptyline
- ofloxacin
- olanzapine: postmarketing, 0% - 7%
- olsalazine
- omeprazole: postmarketing
- ondansetron: postmarketing
- orphenadrine
- oxaliplatin: very common
- oxaprozin
- oxazepam
- oxcarbazepine: common, 0% - 16%
- oxycodone
- paclitaxel
- paliperidone: common, 2% - 12%
- pantoprazole: postmarketing
- paraldehyde
- paroxetine: very rare, postmarketing, uncommon, common, 0% - 14.7%
- penicillin
- pentamidine
- pentazocine
- pentoxifylline: 0.3%
- pergolide: frequent, 4.2%
- perhexiline
- perindopril erbumine
- phendimetrazine
- phenelzine
- phentermine
- phenylephrine
- phenylpropanolamine
- phenytoin: 3.3% - 13.1%
- pilocarpine
- pimozide: postmarketing, 2.78%
- pindolol
- pirbuterol: 1.3% - 6%
- piroxicam
- pomalidomide: 9.35% - 12.5%
- posaconazole
- potassium phosphate
- pramipexole: 3%
- pravastatin
- pregabalin: 1% - 8%
- prilocaine
- procaine
- procarbazine
- prochlorperazine
- progesterone
- promethazine
- propafenone: 0% - 2.21%
- propericiazine
- propofol
- prostacyclin: 9% - 21%
- protriptyline
- prucalopride: uncommon
- quetiapine: 2% - 8%
- quinidine: 2% - 6%
- rabeprazole
- raltegravir
- ramipril
- ramiprilat
- ranolazine: postmarketing
- rapamycin: 18% - 31%
- rasagiline: frequent
- reboxetine: 1.87%
- regadenoson: postmarketing, uncommon
- regorafenib
- remifentanil
- retigabine: 3% - 12%
- retinoic acid
- ribavirin: common
- rifapentine
- rifaximin
- riluzole: frequent
- rimantadine
- rimonabant
- risperidone: 0% - 24%
- ritonavir
- rivastigmine: common, very common, 1% - 23%
- rizatriptan: frequent
- roflumilast
- ropinirole: infrequent, 6%
- ropivacaine: 0.2% - 1.2%
- rotigotine: 4%
- rufinamide: 6%
- salbutamol: postmarketing, common, very common, 0% - 35%
- salmeterol: common, 0.797% - 7.79%
- salmon calcitonin acetate: postmarketing
- saquinavir
- scopolamine
- sertraline: very common, 1% - 11%
- sibutramine
- sildenafil
- simvastatin
- sitaxsentan
- sparfloxacin: postmarketing
- sumatriptan: very rare, postmarketing, infrequent
- tacrolimus: very common, 4.5% - 56%
- tapentadol: 1% - 3%
- telavancin: uncommon
- temazepam
- temozolomide: common
- terazosin
- terbutaline: 7.8% - 38%
- testosterone undecanoate
- tetracaine
- tetrahydrozoline
- thalidomide: 0% - 26.5%
- theophylline: 14% - 38%
- thioridazine: postmarketing
- thyroxine
- tiagabine: 1% - 21%
- tiaprofenic acid
- tigecycline
- tizanidine: postmarketing, infrequent
- tolcapone: frequent
- topiramate: 0% - 10.6%
- toremifene
- tramadol: postmarketing, rare, 0.5%
- tranylcypromine
- trazodone: 2.8% - 5.1%
- triazolam
- trifluoperazine
- trimethoprim: very rare
- trimipramine
- trovafloxacin
- v 1784: postmarketing, very common, 0% - 55%
- valdecoxib
- valganciclovir: 2% - 28%
- valproate: 1.4% - 57%
- vandetanib
- varenicline: infrequent, uncommon
- vasopressin
- venlafaxine: postmarketing, common, 1% - 10.2%
- verapamil
- vigabatrin: common, 6% - 16%
- vilazodone: 2%
- vildagliptin: common
- vinflunine
- voriconazole: common
- zalcitabine
- zaleplon: 2%
- ziconotide: 7%
- zidovudine: postmarketing
- zidovudine/lamivudine
- ziprasidone: frequent, 2.5%
- zoledronic acid: postmarketing, uncommon
- zolmitriptan: infrequent
- zolpidem: infrequent, 1%
- zonisamide: frequent
- zopiclone: rare
- zuclopenthixol
|
Drugs with this indication
|